Advertisement

Cell-Based Tachyarrhythmias and Bradyarrhythmias

  • Rohin K. Reddy
  • Ben N. Cullen
  • Ahran D. ArnoldEmail author
  • Zachary I. Whinnett
Chapter
Part of the Learning Materials in Biosciences book series (LMB)

Abstract

Arrhythmias can have immediate clinical consequences because effective cardiac output is determined by efficient electromechanical coupling of the myocardium and coordination between and within cardiac chambers. This chapter will discuss specific bradyarrhythmias and tachyarrhythmias, providing an overview of their pathophysiology, clinical characteristics and treatment options. As the heart constitutes a functional syncytium, the cellular basis of arrhythmia will first be discussed before considering its effects across the larger myocardial mass as well as clinical manifestations.

References

  1. 1.
    Konety SH, Koene RJ, Norby FL, Wilsdon T, Alonso A, Siscovick D et al (2016) Echocardiographic predictors of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. Circ Cardiovasc Imaging 9(8):e004431CrossRefPubMedGoogle Scholar
  2. 2.
    Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP et al (2011) Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation 123:2423CrossRefPubMedGoogle Scholar
  3. 3.
    Waller AD (1887) A demonstration on man of electromotive changes accompanying the Heart’s beat. J Physiol 8:229CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Barold SS (2003) Willem Einthoven and the birth of clinical electrocardiography a hundred years ago. Card Electrophysiol Rev 7(1):99–104CrossRefPubMedGoogle Scholar
  5. 5.
    Scherlag BJ, Lau SH, Helfant RH, Berkowitz WD, Stein E, Damato AN (1969) Catheter technique for recording his bundle activity in man. Circulation 39:13CrossRefPubMedGoogle Scholar
  6. 6.
    Lüderitz B (2009) Historical perspectives of cardiac electrophysiology. Hell J Cardiol 50(1):3–16Google Scholar
  7. 7.
    Tse G (2016) Mechanisms of cardiac arrhythmias. J Arrhythmia 32:75CrossRefGoogle Scholar
  8. 8.
    Qu Z, Xie LH, Olcese R, Karagueuzian HS, Chen PS, Garfinkel A et al (2013) Early afterdepolarizations in cardiac myocytes: beyond reduced repolarization reserve. Cardiovasc Res 99:6CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Liu GX, Choi BR, Ziv O, Li W, de Lange E, Qu Z et al (2012) Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits. J Physiol 590:1171CrossRefPubMedGoogle Scholar
  10. 10.
    Zeng J, Rudy Y (1995) Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J 68:949CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Viswanathan PC, Rudy Y (1999) Pause induced early afterdepolarizations in the long QT syndrome: a simulation study. Cardiovasc Res 42:530CrossRefPubMedGoogle Scholar
  12. 12.
    Xie JT, Lowell TK, Yuan CS (2000) Extracellular detection of delayed afterdepolarization of cardiac fibers using signal averaging technique. Acta Pharmacol Sin 21(11):977–985PubMedPubMedCentralGoogle Scholar
  13. 13.
    BOUTJDIR M, ASSADI M, El-SHERIF N (1995) Electrophysiologic effects of cocaine on subendocardial Purkinje fibers surviving 1 day of myocardial infarction. J Cardiovasc Electrophysiol 6:729CrossRefPubMedGoogle Scholar
  14. 14.
    Nattel S, Carlsson L (2006) Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 5:1034CrossRefGoogle Scholar
  15. 15.
    Quan W, Rudy Y (1990) Unidirectional block and reentry of cardiac excitation: a model study. Circ Res 66:367CrossRefPubMedGoogle Scholar
  16. 16.
    MacLeod K (2014) An essential introduction to cardiac electrophysiology [internet]. Imperial College Press, [cited 2019 Jan 3]Google Scholar
  17. 17.
    Spodick DH, Raju P, Bishop RL, Rifkin RD (1992) Operational definition of normal sinus heart rate. Am J Cardiol 69:1245CrossRefPubMedGoogle Scholar
  18. 18.
    Fagard R (2002) Athlete’s heart. Heart 89(12):1455–1461CrossRefGoogle Scholar
  19. 19.
    Jensen PN, Gronroos NN, Chen LY, Folsom AR, Defilippi C, Heckbert SR et al (2014) Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol 64:531CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM et al (2012) Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc 60:34CrossRefPubMedGoogle Scholar
  21. 21.
    Dakkak W, Rhythm DR (2017) Sick sinus syndrome. StatPearls, Treasure IslandGoogle Scholar
  22. 22.
    Prystowsky EN (1988) The effects of slow channel blockers and beta blockers on atrioventricular nodal conduction. J Clin Pharmacol 28:6CrossRefPubMedGoogle Scholar
  23. 23.
    Abraham S, Reddy S, Abboud J, Jonnalagadda K, Ghanta SK, Kondamudi V (2010) Brief, recurrent, and spontaneous episodes of loss of consciousness in a healthy young male. Int Med Case Rep J 3:71–76CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Barold SS, Hayes DL (2001) Second-degree atrioventricular block: a reappraisal. Mayo Clin Proc 76:44CrossRefPubMedGoogle Scholar
  25. 25.
    Jones WM, Rhythm NL (2018) Atrioventricular block, second-degree. StatPearls, Treasure IslandGoogle Scholar
  26. 26.
    Adams MG, Pelter MM (2003) Ventricular escape rhythms. Am J Crit Care 12(5):477–478PubMedPubMedCentralGoogle Scholar
  27. 27.
    SCHER AM, RODRIGUEZ MI, LIIKANE J, YOUNG AC (1959) The mechanism of atrioventricular conduction. Circ Res 7:54CrossRefPubMedGoogle Scholar
  28. 28.
    Narula OS, Scherlag BJ, Samet P, Javier RP (1971) Atrioventricular block. Localization and classification by his bundle recordings. Am J Med 50(2):146–165CrossRefPubMedGoogle Scholar
  29. 29.
    Palatini P (1999) Need for a revision of the normal limits of resting heart rate. Hypertension 33:622CrossRefPubMedGoogle Scholar
  30. 30.
    Whinnett Z, Sohaib SA, Davies DW (2012) Diagnosis and management of supraventricular tachycardia. Br Med J 345:e7769CrossRefGoogle Scholar
  31. 31.
    Kannel W, Wolf P, Benjamin E, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available. Am J Cardiol 82:2NCrossRefPubMedGoogle Scholar
  32. 32.
    Nattel S, Dobrev D (2016) Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol 13:575CrossRefPubMedGoogle Scholar
  33. 33.
    Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92:1954CrossRefPubMedGoogle Scholar
  34. 34.
    Patel P, Pandya J, Goldberg M (2017) NOACs vs. Warfarin for stroke prevention in Nonvalvular atrial fibrillation. Cureus 9(6):e1395PubMedPubMedCentralGoogle Scholar
  35. 35.
    Katritsis DG, Josephson ME (2016) Classification, electrophysiological features and therapy of atrioventricular nodal reentrant tachycardia. Arrhythmia Electrophysiol Rev 5:130CrossRefGoogle Scholar
  36. 36.
    Schluter M, Geiger M, Siebels J, Duckeck W, Kuck KH (1991) Catheter ablation using radiofrequency current to cure symptomatic patients with tachyarrhythmias related to an accessory atrioventricular pathway. Circulation 84:1644CrossRefPubMedGoogle Scholar
  37. 37.
    Keating L, Morris FP (2003) Electrocardiographic features of Wolff-Parkinson-white syndrome. Emerg Med J 20:491CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Sohinki D, Obel OA (2014) Current trends in supraventricular tachycardia management. Ochsner J 14(4):586–595PubMedPubMedCentralGoogle Scholar
  39. 39.
    Benito B, Guasch E, Rivard L, Nattel S (2010) Clinical and mechanistic issues in early repolarization: of normal variants and lethal arrhythmia syndromes. J Am Coll Cardiol 56:1177CrossRefPubMedGoogle Scholar
  40. 40.
    de Luna AB, Coumel P, Leclercq JF (1989) Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117(1):151–159CrossRefGoogle Scholar
  41. 41.
    Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 324:781CrossRefPubMedGoogle Scholar
  42. 42.
    Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al (2018) AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 15(10):e190–e252Google Scholar
  43. 43.
    Muser D, Santangeli P, Castro SA, Pathak RK, Liang JJ, Hayashi T et al (2016) Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy. Circ Arrhythmia Electrophysiol 9(10):e004328CrossRefGoogle Scholar
  44. 44.
    van Herendael H, Dorian P (2010) Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. Vasc Health Risk Manag 6:465–472PubMedPubMedCentralGoogle Scholar
  45. 45.
    Guan Yap Y, John Camm A, Yap YG, Camm AJ (2012) Drug induced QT prolongation and torsades de pointes. Heart 2003;89:1363–1372.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G et al (2006) 2006 ACC/AHA/ESC guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 114:e385–e484Google Scholar
  47. 47.
    Moe GK, Abildskov JA (1959) Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 58:59CrossRefPubMedGoogle Scholar
  48. 48.
    Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339(10):659–666 [Internet]. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM199809033391003.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Rohin K. Reddy
    • 1
    • 2
  • Ben N. Cullen
    • 2
  • Ahran D. Arnold
    • 3
    Email author
  • Zachary I. Whinnett
    • 3
  1. 1.Hull York Medical SchoolYorkUK
  2. 2.Imperial College LondonLondonUK
  3. 3.National Heart and Lung Institute, Imperial College LondonLondonUK

Personalised recommendations